Consensus Qingdao Haier Biomedical Co.,Ltd

Equities

688139

CNE100003P25

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
39.6 ^CNY	+0.92%		+6.28%	-2.27%

Apr. 25	Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Qingdao Haier Biomedical Co.,Ltd's Equity Buyback Plan announced on February 9, 2024.	CI

Evolution of the average Target Price on Qingdao Haier Biomedical Co.,Ltd

Price target over the last 5 years

History of analyst recommendation changes

22e0d58bf7635fa60cc55503f9ea43b3._5EX1LuRqU-aCylYkKRte9_tKLu7NMPgZ28pqSRkjz8.yPdducz25H_gMwQ8xsZZN768afGCYrPYIS52-E9J5mDSoHiE2P3IKMw8ZA~13dac0c6c1bb99243ffb5fff0654268d

Analyst Recommendations on Qingdao Haier Biomedical Co.,Ltd

Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 80 Yuan From 100 Yuan, Keeps at Buy	23-10-27	MT
Jefferies Adjusts Qingdao Haier Biomedical's Price Target to 100 Yuan From 120 Yuan, Keeps at Buy	23-08-30	MT
Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 120 Yuan From 126 Yuan, Keeps at Buy	23-03-30	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

39.6 CNY

Average target price

57.5 CNY

Spread / Average Target

+45.20%

High Price Target

80 CNY

Spread / Highest target

+102.02%

Low Price Target

35 CNY

Spread / Lowest Target

-11.62%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Qingdao Haier Biomedical Co.,Ltd

Jefferies & Co.

Ratings for Qingdao Haier Biomedical Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar